Cargando…

Randomized Trial of Time-Limited Interruptions of Protease Inhibitor-Based Antiretroviral Therapy (ART) vs. Continuous Therapy for HIV-1 Infection

BACKGROUND: The clinical outcomes of short interruptions of PI-based ART regimens remains undefined. METHODS: A 2-arm non-inferiority trial was conducted on 53 HIV-1 infected South African participants with viral load <50 copies/ml and CD4 T cell count >450 cells/µl on stavudine (or zidovudine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Firnhaber, Cynthia, Azzoni, Livio, Foulkes, Andrea S., Gross, Robert, Yin, Xiangfan, Van Amsterdam, Desiree, Schulze, Doreen, Glencross, Deborah K., Stevens, Wendy, Hunt, Gillian, Morris, Lynn, Fox, Lawrence, Sanne, Ian, Montaner, Luis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125169/ https://www.ncbi.nlm.nih.gov/pubmed/21738668 http://dx.doi.org/10.1371/journal.pone.0021450

Ejemplares similares

Metabolic and anthropometric parameters contribute to ART-mediated CD4(+ )T cell recovery in HIV-1-infected individuals: an observational study
por: Azzoni, Livio, et al.
Publicado: (2011)

Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women
por: Azzoni, Livio, et al.
Publicado: (2010)

Tree-Based Methods for Discovery of Association between Flow Cytometry Data and Clinical Endpoints
por: Eliot, M., et al.
Publicado: (2009)

Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection
por: Papasavvas, Emmanouil, et al.
Publicado: (2004)

Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa
por: Firnhaber, Cynthia, et al.
Publicado: (2012)

Incident Pregnancy and Time to Death or AIDS among HIV-Positive Women Receiving Antiretroviral Therapy
por: Westreich, Daniel, et al.
Publicado: (2013)

Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset
por: Azzoni, Livio, et al.
Publicado: (2015)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy
por: Evans, Denise, et al.
Publicado: (2013)

Progression of cervical neoplasia in HIV-seropositive women with and without antiretroviral therapy in Johannesburg, South Africa
por: Firnhaber, Cynthia, et al.
Publicado: (2010)

Addressing antiretroviral therapy-related diagnostic coverage gaps across South Africa using a programmatic approach
por: Cassim, Naseem, et al.
Publicado: (2018)

Breast abnormalities in adolescents receiving antiretroviral therapy
por: Dunlop, Jackie L., et al.
Publicado: (2019)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
por: Bonney, Evelyn Y., et al.
Publicado: (2021)

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
por: Harrison, Linda, et al.
Publicado: (2012)

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy
por: Gianella, Sara, et al.
Publicado: (2016)

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
por: Paci, Paola, et al.
Publicado: (2009)

Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa
por: Wallis, Carole L., et al.
Publicado: (2011)

Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption
por: Ziani, Widade, et al.
Publicado: (2021)

Association between HIV in pregnancy and antiretroviral therapy, including protease inhibitors and low birth weight infants.
por: Goldstein, P J, et al.
Publicado: (2000)

Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model
por: Harris, Rebecca Arden, et al.
Publicado: (2018)

Predictors of antiretroviral therapy interruptions and factors influencing return to care at the Nkolndongo Health District, Cameroon
por: Nsoh, Marius, et al.
Publicado: (2021)

Prioritizing CD4 Count Monitoring in Response to ART in Resource-Constrained Settings: A Retrospective Application of Prediction-Based Classification
por: Azzoni, Livio, et al.
Publicado: (2012)

Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial
por: Belaunzarán-Zamudio, Pablo F., et al.
Publicado: (2017)

Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings
por: Lima, Viviane D, et al.
Publicado: (2016)

The Impact of Combination Antiretroviral Therapy and its Interruption on Anxiety, Stress, Depression and Quality of Life in Thai Patients
por: Nüesch, Reto, et al.
Publicado: (2009)

Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study
por: Machado, Carmen, et al.
Publicado: (2012)

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
por: Hill, Alison L., et al.
Publicado: (2016)

High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria
por: Ahonkhai, Aimalohi A., et al.
Publicado: (2015)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals
por: Clarridge, Katherine E., et al.
Publicado: (2018)

Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice
por: Ventura, John D., et al.
Publicado: (2019)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
por: Maria, Suzy, et al.
Publicado: (2020)

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
por: Li, Miaomiao, et al.
Publicado: (2021)

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
por: Lau, Jillian SY., et al.
Publicado: (2021)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
por: Zacharopoulou, P., et al.
Publicado: (2022)

Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy
por: Yang, Hailiu, et al.
Publicado: (2012)

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
por: Musana, Hellen, et al.
Publicado: (2021)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Identification of a 251 Gene Expression Signature That Can Accurately Detect M. tuberculosis in Patients with and without HIV Co-Infection
por: Dawany, Noor, et al.
Publicado: (2014)

Treatment outcomes of over 1000 patients on second‐line, protease inhibitor‐based antiretroviral therapy from four public‐sector HIV treatment facilities across Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2016)

Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy
por: Weiss, Laurence, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tp5evbaor66f1b6qekdeibhpl0